Ella Therapeutics

Microbiome-based Products for Combination Therapy with Immuno-oncology

Health Tech & Life Sciences
Non Active, Jul 2022 ceased to operate
Pre-Funding Ramat Gan, Israel Founded 2019
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2019
Headcount
1-10
HQ
Ramat Gan, Israel
Sector
Health Tech & Life Sciences

About

Ella Therapeutics is developing microbiome-based products for combination therapy with immuno-oncology. Ella Therapeutics' mission is to overcome immunotherapy resistance in cancer patients through alteration of the gut microbiome via engineered bacteria or a live biotherapeutic product. The company's platform is for all major cancer indications and was developed with the aim of saving lives that were otherwise lost due to patients' bodies' resistance to medicine.

Q&A

What is Ella Therapeutics' primary focus?
Ella Therapeutics is developing microbiome-based products for combination therapy with immuno-oncology, aiming to overcome immunotherapy resistance in cancer patients.
When was Ella Therapeutics founded?
Ella Therapeutics was founded in May 2019.
What is the current status of Ella Therapeutics?
Ella Therapeutics is currently inactive, having ceased to operate in July 2022.
Where is Ella Therapeutics headquartered?
Ella Therapeutics is headquartered in Ramat Gan, Israel.
What is Ella Therapeutics' employee count?
Ella Therapeutics has 1-10 employees.
Who are the co-founders of Ella Therapeutics?
The co-founders of Ella Therapeutics are Yaron Lemelbaum, who serves as Co-founder & CEO, and Gal Markel, who serves as Co-founder & CMO.
What sector does Ella Therapeutics primarily operate in?
Ella Therapeutics primarily operates in the Health Tech & Life Sciences sector.
What is the product stage of Ella Therapeutics?
Ella Therapeutics' product is in the clinical trial stage.

Team · 2

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CMO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

oncologycancermicrobiomeimmunotherapybiopharmaceuticalbioinformaticsbiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)